News Item
Parsippany, NJ (December 15th, 2008) - Diagnostica Stago, Inc. is proud to introduce that the newest member of the STA® family of coagulation analyzers, the STA Satellite®, has received FDA 510(k) clearance. A fully automated benchtop analyzer, it is capable of simultaneously performing clotting, chromogenic and immunological assays. The STA Satellite® offers complete automation to the low volume coagulation laboratory and is also a perfect solution for satellite labs. The analyzer provides system reliability and ease of operation, while ensuring flexibility and complete security, all within a small footprint. Designed for the low-volume laboratory segment, or the low to mid volume coumadin clinic, the analyzer is capable of running PT, APTT, Fibrinogen, D-dimer, Antithrombin, and Heparin anti-Xa, with 20 on-board sample positions, and STAT capability.
Melissa Cole, Instrument Product Manager, comments, "The STA Satellite® combines our patented VDS technology, barcoded pre-calibrated reagent line, and Stago services – all on an analyzer suited to the low-volume coagulation lab. In addition to the STA-R Evolution® and STA Compact®, the STA Satellite® enables Integrated Health networks (IHN) to standardize patient testing results including d-dimer and heparin anti-Xa from small to large healthcare facilities."
Diagnostica Stago, Inc. offers a complete line of instrumentation and reagents for hemostasis and coagulation testing. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, Asnières, France. For more information on the STA Satellite® (Cat.# 58104) please call 800-222-COAG or visit our website at www.stago-us.com.
